Variant NM_000492.4:c.1680-886A>G
| Name | NM_000492.4:c.1680-886A>G |
| Protein name | NP_000483.3:p.(=) |
| Genomic name (hg19) | chr7:g.117229521A>G UCSC |
| Genomic name (hg38) | chr7:g.117589467A>G UCSC |
| #Exon/intron | intron 12 |
| Legacy Name | 1811+1.6kbA>G |
| Class | disease-causing |
| Subclass | CF-causing |
| WT sequence | ACAGAGAATCCTATGTACTTGAGAT A TAAGTAAGGTTACTATCAATCACAC |
| Mutant sequence | ACAGAGAATCCTATGTACTTGAGAT G TAAGTAAGGTTACTATCAATCACAC |
![]() |
![]() | dbSNP rs397508266 |
![]() Not found | ![]() |
| Reference | PMID | Modulator | in vitro / ex vivo data | clinical data | Patient responsiveness |
| Burgel et al., 2024 | 39151434 | ELX-TEZ-IVA | N.D. | yes | no |
No patient found in CFTR-NGS catalogue |
| TOTAL NUMBER OF PATIENTS | 28 |
|---|---|
| CF | 27 |
| CFTR-RD | 1
|
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| Phenotype | Patient ID | Variant status | Additional variants |
|---|---|---|---|
| CF | 36 | heterozygote | CF-causing - Trans |
| CF | 954 | heterozygote | CF-causing - Trans |
| CF | 960 | heterozygote | CF-causing - Trans |
| CF | 4786 | heterozygote | CF-causing- Undef |
| CF | 1103 | heterozygote | CF-causing - Trans |
| CF | 1190 | heterozygote | CF-causing - Trans |
| CF | 1211 | heterozygote | CF-causing- Undef |
| CF | 1223 | heterozygote | CF-causing - Trans |
| CF | 1605 | heterozygote | CF-causing- Undef |
| CF | 1638 | heterozygote | CF-causing- Undef |
| CF | 1913 | heterozygote | CF-causing- Undef |
| CF | 2178 | heterozygote | CF-causing- Undef |
| CF | 869 | heterozygote | CF-causing - Trans |
| CF | 846 | heterozygote | CF-causing - Trans |
| CF | 196 | heterozygote | CF-causing- Undef |
| CF | 198 | heterozygote | CF-causing- Undef |
| CF | 199 | heterozygote | CF-causing- Undef |
| CF | 201 | heterozygote | CF-causing- Undef |
| CF | 216 | heterozygote | CF-causing - Trans |
| CF | 244 | heterozygote | CF-causing - Trans |
| CF | 6527 | heterozygote | CF-causing- Undef |
| CF | 247 | heterozygote | VUS3 - Trans |
| CF | 255 | heterozygote | CF-causing - Trans |
| CF | 617 | heterozygote | varying clinical consequence- Undef |
| CF | 1074 | homozygote | c.1680-886A>G - p.(=) - Trans |
| CF | 772 | homozygote | c.1680-886A>G - p.(=) - Trans |
| CF | 1199 | homozygote | c.1680-886A>G - p.(=) - Trans |
| CBAVD | 530 | heterozygote | varying clinical consequence- Undef |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| CFTR variants are clustered into five groups (click here for more details about the classification of variants): |
|